Antibiotic Tolerance in Environmentally Stressed : Physical Barriers and Induction of a Viable but Nonculturable State
Overview
Authors
Affiliations
Bacterial communities exposed to rapid changes in their habitat encounter different forms of stress. Fluctuating conditions of the microenvironment drive microorganisms to develop several stress responses to sustain growth and division, like altering gene expression and changing the cell's physiology. It is commonly known that these protection systems may give rise to differently adapted subpopulations and indirectly impact bacterial susceptibility to antimicrobials. This study focuses on the adaptation of a soil-dwelling bacterium, , to sudden osmotic changes, including transient and sustained osmotic upshift. Here, we demonstrate that physiological changes caused by pre-exposure to osmotic stress facilitate ' entry into a quiescent state, helping them survive when exposed to a lethal antibiotic concentration. We show that the adaptation to transient osmotic upshift with 0.6 M NaCl causes decreased metabolic rates and lowered antibiotic-mediated ROS production when cells were exposed to the aminoglycoside antibiotic kanamycin. Using a microfluidic platform combined with time-lapse microscopy, we followed the uptake of fluorescently labelled kanamycin and examined the metabolic activity of differently preadapted populations at a single-cell level. The microfluidics data revealed that under the conditions tested, escapes from the bactericidal activity of kanamycin by entering into a nongrowing dormant state. Combining single-cell studies and population-wide analysis of differently preadapted cultures, we demonstrate that kanamycin-tolerant cells are entrapped in a viable but nonculturable (VBNC) state.
Living Microneedles for Intradermal Delivery of Beneficial Bacteria.
Alperovitz C, Ben David N, Ramot Y, Gross A, Mizrahi B ACS Biomater Sci Eng. 2025; 11(2):1232-1241.
PMID: 39828947 PMC: 11815633. DOI: 10.1021/acsbiomaterials.4c02230.
Creating Single-Cell Protein-Producing Mutants Using Chemical Mutagen and Amino Acid Inhibitors.
Berzina I, Kalnins M, Geiba Z, Raita S, Palcevska J, Mika T Scientifica (Cairo). 2024; 2024:8968295.
PMID: 39649941 PMC: 11623996. DOI: 10.1155/sci5/8968295.
Garcia-Morena D, Fernandez-Cantos M, Escalera S, Lok J, Iannone V, Cancellieri P Probiotics Antimicrob Proteins. 2024; .
PMID: 38319537 DOI: 10.1007/s12602-024-10219-1.
Morawska L, Kuipers O Sci Rep. 2022; 12(1):18015.
PMID: 36289289 PMC: 9605947. DOI: 10.1038/s41598-022-21102-w.